← HHS Federal Register rules

Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Meprobamate Test System

fda-device · Food and Drug Administration · Rule · Published 2018-11-01 · Effective 2018-11-01 · 83 FR 54875

Document

Document number
2018-23911
Federal Register citation
83 FR 54875
CFR reference
21 CFR 862
Type
Rule
Action
Final order.
Category
fda-device
Sub-agency
Food and Drug Administration
Publication date
2018-11-01
Effective date
2018-11-01
HHS docket
Docket No. FDA-2018-N-3694

Abstract

The Food and Drug Administration (FDA or we) is classifying the meprobamate test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the meprobamate test system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Source

Authoritative
Federal Register document
Machine
JSON-LD · Markdown